How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review

被引:149
|
作者
Freeman, Abigail M. [1 ]
Petrilli, Katherine [1 ]
Lees, Rachel [1 ,2 ]
Hindocha, Chandni [1 ,4 ]
Mokrysz, Claire [1 ]
Curran, H. Valerie [1 ]
Saunders, Rob [1 ]
Freeman, Tom P. [1 ,2 ,3 ]
机构
[1] UCL, Clin Psychopharmacol Unit, Gower St, London WC1E 6BT, England
[2] Univ Bath, Addict & Mental Hlth Grp AIM, Bath BA2 7AY, Avon, England
[3] Kings Coll London, Natl Addict Ctr, London SE5 8BB, England
[4] UCL, Div Psychiat, Res Dept Mental Hlth Neurosci, Translat Psychiat Res Grp, Gower St, London WC1E 6BT, England
来源
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS | 2019年 / 107卷
关键词
ACUTE ORAL DELTA(9)-TETRAHYDROCANNABINOL; PERSECUTORY IDEATION; DOUBLE-BLIND; CANNABINOIDS; MEMORY; RECEPTOR; TETRAHYDROCANNABINOL; EXPERIENCES; COGNITION; SYMPTOMS;
D O I
10.1016/j.neubiorev.2019.09.036
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The recent liberalisation of cannabis regulation has increased public and scientific debate about its potential benefits and risks. A key focus has been the extent to which cannabidiol (CBD) might influence the acute effects of delta-9-tetrahydrocannabinol (THC), but this has never been reviewed systematically. In this systematic review of how CBD influences the acute effects of THC we identified 16 studies involving 466 participants. Ten studies were judged at low risk of bias. The findings were mixed, although CBD was found to reduce the effects of THC in several studies. Some studies found that CBD reduced intense experiences of anxiety or psychosis-like effects of THC and blunted some of the impairments on emotion and reward processing. However, CBD did not consistently influence the effects of THC across all studies and outcomes. There was considerable heterogeneity in dose, route of administration and THC:CBD ratio across studies and no clear dose-response profile emerged. Although findings were mixed, this review suggests that CBD may interact with some acute effects of THC.
引用
收藏
页码:696 / 712
页数:17
相关论文
共 47 条
  • [31] Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study
    Chester, Lucy A. A.
    Englund, Amir
    Chesney, Edward
    Oliver, Dominic
    Wilson, Jack
    Sovi, Simina
    Dickens, Alex M. M.
    Oresic, Matej
    Linderman, Tuomas
    Hodsoll, John
    Minichino, Amedeo
    Strang, John
    Murray, Robin M. M.
    Freeman, Tom P. P.
    McGuire, Philip
    CANNABIS AND CANNABINOID RESEARCH, 2024, 9 (01) : 188 - 198
  • [32] Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain
    Britch, Stevie C.
    Goodman, Alan G.
    Wiley, Jenny L.
    Pondelick, Abby M.
    Craft, Rebecca M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2020, 373 (03): : 416 - 428
  • [33] Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
    Hindocha, Chandni
    Freeman, Tom P.
    Schafer, Grainne
    Gardener, Chelsea
    Das, Ravi K.
    Morgan, Celia J. A.
    Curran, H. Valerie
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (03) : 325 - 334
  • [34] Effects of in utero delta-9-tetrahydrocannabinol (THC) exposure on fetal and infant musculoskeletal development in a preclinical nonhuman primate model
    Moellmer, Samantha A.
    Hagen, Olivia L.
    Farhang, Parsa A.
    Duke, Victoria R.
    Fallon, Meghan E.
    Hinds, Monica T.
    McCarty, Owen J. T.
    Lo, Jamie O.
    Nakayama, Karina H.
    PLOS ONE, 2024, 19 (07):
  • [35] Differential Effects of D9 Tetrahydrocannabinol (THC)- and Cannabidiol (CBD)-Based Cannabinoid Treatments on Macrophage Immune Function In Vitro and on Gastrointestinal Inflammation in a Murine Model
    Yekhtin, Zhanna
    Khuja, Iman
    Meiri, David
    Or, Reuven
    Almogi-Hazan, Osnat
    BIOMEDICINES, 2022, 10 (08)
  • [36] Acute and Chronic Effects of Cannabidiol on Δ9-Tetrahydrocannabinol (Δ9-THC)-Induced Disruption in Stop Signal Task Performance
    Jacobs, David S.
    Kohut, Stephen J.
    Jiang, Shan
    Nikas, Spyros P.
    Makriyannis, Alexandros
    Bergman, Jack
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2016, 24 (05) : 320 - 330
  • [37] Does variation in trait schizotypy and frequency of cannabis use influence the acute subjective, cognitive and psychotomimetic effects of delta-9-tetrahydrocannabinol? A mega-analysis
    Freeman, Abigail M.
    Mokrysz, Claire
    Hindocha, Chandni
    Lawn, Will
    Morgan, Celia J. A.
    Freeman, Tom P.
    Saunders, Rob
    Curran, H. Valerie
    JOURNAL OF PSYCHOPHARMACOLOGY, 2021, 35 (07) : 804 - 813
  • [38] Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies
    De Aquino, Joao P.
    Bahji, Anees
    Gomez, Oscar
    Sofuoglu, Mehmet
    DRUG AND ALCOHOL DEPENDENCE, 2022, 241
  • [39] Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations
    Moore, Catherine F.
    Weerts, Elise M.
    PSYCHOPHARMACOLOGY, 2022, 239 (05) : 1397 - 1408
  • [40] Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations
    Catherine F. Moore
    Elise M. Weerts
    Psychopharmacology, 2022, 239 : 1397 - 1408